# GLP-1s and pregnancy · PepVault guides

Source: https://pepvault.app/guides/glp-1s-and-pregnancy

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during

Reviewed November 2026 14 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Ozempic, Wegovy, Mounjaro and Zepbound in pregnancy: each label's stop-before line, the pill warning, breastfeeding, wash-out times and what 2026 studies found.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 14
- **Questions:** 7
- **Compounds:** 2

## The short answer

The Ozempic and Wegovy labels say to stop semaglutide at least 2 months before a planned pregnancy, because it lingers in the blood for 5 to 7 weeks. The Mounjaro and Zepbound labels set no such interval: tirzepatide's half-life is about 5 days, and Zepbound's label says to stop once a pregnancy is known. US obstetricians advise 1 to 2 months for any GLP-1. Your prescriber sets the date.

Every number checked at its primary source · Nov 20, 2026 · [14 sources](https://pepvault.app/guides/glp-1s-and-pregnancy#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** FDA labels (DailyMed) for the four brands, observational cohort studies and one meta-analysis of pregnancies exposed to GLP-1s, two milk studies (one on each label for tirzepatide) and animal reproduction studies on the labels; no randomised trial in pregnancy exists, and pregnant women were excluded from the drugs' trials.

## When do you stop Ozempic, Wegovy, Mounjaro or Zepbound before getting pregnant?

The four labels do not say the same thing, and most pages that answer this question merge them into one "two months" rule. Only the two semaglutide labels set a stop date before a planned pregnancy. The two tirzepatide labels have no interval at all; what they add instead is a warning about the birth-control pill. Here is each label's own line, from the versions on DailyMed as of November 20, 2026[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) [2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) [3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) [4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4):

| Label | Before a planned pregnancy | Once pregnant | Breastfeeding | The pill |
| --- | --- | --- | --- | --- |
| Ozempic (semaglutide, type 2 diabetes) | Stop at least 2 months before, "due to the long washout period"[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) | Use only if the potential benefit justifies the potential risk to the fetus[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) | No human data; found in rat milk at 3 to 12 times lower levels than in the mother's blood[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) | Tested with ethinyl estradiol and levonorgestrel; no contraception step on the label[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) |
| Wegovy (semaglutide, weight) | Stop at least 2 months before, "to account for the long half-life" (for liver disease, MASH, only where the risk outweighs the benefit)[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) | Stop if it is used for weight or heart-risk reduction; for MASH, only if the benefit justifies the risk; a pregnancy registry exists[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) | Tablets: not recommended; injection: no human data[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) | No clinically significant change[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) |
| Mounjaro (tirzepatide, type 2 diabetes) | No interval given[3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) | Use only if the potential benefit justifies the potential risk to the fetus[3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) | Undetectable or low in a study of 11 women[3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) | Switch to a non-oral method, or add a barrier method, for 4 weeks after starting and after each dose increase[3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) |
| Zepbound (tirzepatide, weight and sleep apnea) | No interval given[4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4) | Stop when a pregnancy is recognized; a pregnancy registry exists[4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4) | Undetectable or low in a study of 11 women[4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4) | The same 4-week rule[4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4) |

The split follows what each drug is for. Wegovy and Zepbound treat weight, and both labels say plainly that "weight loss offers no benefit to a pregnant patient and may cause fetal harm", so the drug stops when the pregnancy is known[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) [4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4); Wegovy's label makes one exception, for MASH, a liver disease it also treats[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2). Ozempic and Mounjaro treat type 2 diabetes, and uncontrolled blood sugar in pregnancy carries its own risks to mother and baby, so those labels leave the choice to a weighing of benefit and risk, which is the prescriber's to make[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) [3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3).

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's dose log keeps the date and amount of every shot you log, so the day of your last dose is on record when your prescriber asks how long it has been.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## How long does each drug take to leave your body?

The stop date comes from the **half-life**, the time it takes for half of the drug in the blood to be cleared. After one half-life half remains, after two a quarter, and after five about 3% (one thirty-second). Semaglutide's half-life is about a week; tirzepatide's is about 5 days, or 5 to 6 days in people with obesity[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) [2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) [3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) [4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4).

| Drug | Half-life on the label | Five half-lives | What the label says |
| --- | --- | --- | --- |
| Ozempic | About 1 week | About 5 weeks | Present in the circulation for about 5 weeks after the last dose[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) |
| Wegovy | About 1 week | About 5 weeks | About 5 to 7 weeks after the last 2.4 mg or 7.2 mg shot or 25 mg tablet[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) |
| Mounjaro | About 5 days | About 25 days | No wash-out time stated[3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) |
| Zepbound | About 5 to 6 days | 25 to 30 days | No wash-out time stated[4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4) |

So the semaglutide labels' 2 months is the 5 to 7 weeks of wash-out with a margin added. Tirzepatide is mostly gone in about four weeks, and no label turns that into a rule. The US obstetricians' college (ACOG) does, for every GLP-1: its October 2026 advisory tells clinicians to consider stopping 1 to 2 months before conception, and if a pregnancy starts on one, to advise against using it for the rest of the pregnancy[14](https://pepvault.app/guides/glp-1s-and-pregnancy#source-14). Which date applies to you is your prescriber's call.

Try it

How Semaglutide builds up

An estimate from a half-life of about 6.9 days, one dose a week for four weeks. The shape of the level, not a measurement.

[Try your own schedule](https://pepvault.app/tools/peptide-half-life-calculator) [Semaglutide in the library](https://pepvault.app/peptides/semaglutide)

<!--promo-->

PepVault's dose log keeps the date and amount of every shot you log, so the day of your last dose is on record when your prescriber asks how long it has been. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1s-and-pregnancy-inline&mt=8)

<!--/promo-->

## Can you get pregnant on a GLP-1, and does it affect the pill?

Yes, and sometimes more easily than before. Extra body weight lowers fertility, and a 2025 review concludes that weight-loss medicines support spontaneous conception and the response to ovulation treatment, while live-birth data are still missing[13](https://pepvault.app/guides/glp-1s-and-pregnancy#source-13). That fits the "Ozempic babies" of the headlines: weight comes off, ovulation returns, and a pregnancy follows.

The pill is the other half. Tirzepatide slows how fast the stomach empties, most after the first dose, and that can lower how much of a birth-control pill is absorbed. Both tirzepatide labels say to switch to a non-oral method, or add a barrier method such as condoms, for the 4 weeks after starting and the 4 weeks after each dose increase[3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) [4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4). Patches, rings, implants, injections and IUDs do not go through the stomach. The semaglutide labels list no such step[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) [2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2). The measured drop in pill hormones, and what it means for hormone therapy, is in our guide to GLP-1s and menopause.

<!--promo-->

PepVault logs the dose with every shot, so the day each step-up began, where the label's 4 weeks start, stays on record. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1s-and-pregnancy-inline&mt=8)

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [IU (international unit)](https://pepvault.app/glossary/iu)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [MASH](https://pepvault.app/glossary/mash)

## What if you find out you're pregnant while taking one?

Most exposures happen this way: a dose in the weeks before a pregnancy test turns positive. The studies of those pregnancies are, so far, reassuring on birth defects. Each compares exposed pregnancies with similar women on other treatment, and none is a randomised trial:

| Study | Who | Major birth defects |
| --- | --- | --- |
| Cesta 2024, Nordic countries, US and Israel[5](https://pepvault.app/guides/glp-1s-and-pregnancy#source-5) | 938 infants exposed around conception, mothers with type 2 diabetes | 8.3% vs 7.8% on insulin; adjusted risk ratio 0.95 (0.72 to 1.26) |
| Dao 2024, six teratology services[6](https://pepvault.app/guides/glp-1s-and-pregnancy#source-6) | 168 pregnancies exposed in the first trimester | 2.6% vs 2.3% with diabetes on other drugs and 3.9% with overweight |
| Brown 2026, US claims[7](https://pepvault.app/guides/glp-1s-and-pregnancy#source-7) | 3,572 pregnancies with a GLP-1 fill in the 90 days before the last period; birth defects counted in 1,499 infants | Continuing vs stopping: ratio 1.21 (0.83 to 1.82), too imprecise to rule a difference in or out |
| Uysal 2026, meta-analysis of 7 cohorts[8](https://pepvault.app/guides/glp-1s-and-pregnancy#source-8) | Over 40,000 exposed pregnancies | First-trimester odds ratio 1.39 (0.73 to 2.65), not significant; one unadjusted signal for urinary-tract defects, put down to confounding by the authors |

In Brown's study, pregnancies that ended without a live birth were 29.7% with continued fills and 27.1% without, a risk ratio of 1.09 (0.98 to 1.23)[7](https://pepvault.app/guides/glp-1s-and-pregnancy#source-7). The meta-analysis found no rise in stillbirth, miscarriage, small babies or preterm birth, and rated its own certainty as low[8](https://pepvault.app/guides/glp-1s-and-pregnancy#source-8). The warnings on the labels come from animals: in rats and rabbits, and for semaglutide in monkeys, fetal harm appeared at exposures near human ones, alongside the drugs' effects on the mothers' weight and food intake[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) [3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3). Those are animal results, and they are why the labels say what they say.

Wegovy and Zepbound each run a pregnancy registry, which collects outcomes from exposed pregnancies; the labels ask patients and clinicians to report to it[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) [4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4).

**When to get help** A positive test while on any of these four is a reason to call your prescriber or obstetrician that week, and anyone taking one for diabetes should ask before stopping, since blood sugar control matters in pregnancy too.

## Does stopping before pregnancy change how the pregnancy goes?

It can, and this is the newest finding. A 2025 study at a US academic health system matched 448 pregnancies after a GLP-1 that was stopped before or early in pregnancy with 1,344 similar pregnancies without one[9](https://pepvault.app/guides/glp-1s-and-pregnancy#source-9). The exposed women gained more weight and had more of the complications that extra gain brings:

| Outcome | Stopped a GLP-1 | Never on one |
| --- | --- | --- |
| Weight gained in pregnancy | 13.7 kg (30 lb) | 10.5 kg (23 lb) |
| More than the recommended gain | 65% | 49% |
| Preterm birth | 17% | 13% |
| Gestational diabetes | 20% | 15% |
| High blood pressure in pregnancy | 46% | 36% |

A 2026 study of semaglutide in a national US records database points at the cause. Women who stopped before pregnancy and women whose use ran into pregnancy had similar raised risks of excess weight gain and gestational diabetes, with no significant difference between the two groups, which the authors read as a rebound after stopping, not an effect of the drug on the baby[10](https://pepvault.app/guides/glp-1s-and-pregnancy#source-10). A Danish nationwide study of 529 exposed pregnancies found more preterm births only among women taking a GLP-1 for diabetes, not for weight[11](https://pepvault.app/guides/glp-1s-and-pregnancy#source-11). The Wegovy and Zepbound labels add that a healthy weight gain is recommended in every pregnancy, including with obesity[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2) [4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4). A plan for the months after the last dose, food and movement, is worth making before the stop date.

**Commonly reported:** hunger and food noise coming back within a few weeks of the last shot, surprise pregnancies after the weight came off, and trouble telling early pregnancy nausea from the drug's.

## Can you take a GLP-1 while breastfeeding?

Every label leaves it to a weighing of benefit and risk, with one firm exception: the Wegovy tablets are not recommended while breastfeeding[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2). They carry SNAC, an absorption helper that does pass into milk, and babies may clear it slowly; the label points to the injection, which has no SNAC, as the alternative[2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2).

- **Tirzepatide:** in a study of 11 women given one 5 mg dose, 164 of 171 milk samples had none detectable, and the total found over 28 days was under 0.02% of the mother's dose[3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3) [4](https://pepvault.app/guides/glp-1s-and-pregnancy#source-4).
- **Injected semaglutide:** the label has no human data[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) [2](https://pepvault.app/guides/glp-1s-and-pregnancy#source-2). In milk samples from 8 women, it was not detected at all; the authors' worst case put the baby's dose at 1.26% of the mother's, against the usual 10% threshold[12](https://pepvault.app/guides/glp-1s-and-pregnancy#source-12).
- **Both:** no data yet on effects on the baby or on milk supply[1](https://pepvault.app/guides/glp-1s-and-pregnancy#source-1) [3](https://pepvault.app/guides/glp-1s-and-pregnancy#source-3).

Whether and when to restart after birth is a decision for you and your prescriber.

## What should you ask your prescriber?

- Which date should my last dose be, given the drug and dose I am on?
- If I take the pill and start or step up tirzepatide, what do I use for the 4 weeks after?
- If I take it for diabetes, what replaces it before and during pregnancy?
- What is my plan for weight, food and blood sugar between the last dose and the birth?
- Can I restart while breastfeeding, and in which form?

For what happens to appetite and weight after the last dose, read our guide to stopping a GLP-1 next.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Novo Nordisk. OZEMPIC (semaglutide) injection, prescribing information (DailyMed, SPL version 20, Jun 10, 2026): sections 8.1, 8.2, 8.3 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
2. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information (DailyMed, SPL version 19, revised 06/2026): sections 8.1, 8.2, 8.3 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. Eli Lilly and Company. MOUNJARO (tirzepatide) injection, prescribing information (DailyMed, SPL version 40, Sep 2, 2026): sections 8.1, 8.2, 8.3 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
4. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information (DailyMed, SPL version 40, revised 08/2026): sections 8.1, 8.2, 8.3 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
5. Cesta CE, Rotem R, Bateman BT, et al. Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. JAMA Intern Med. 2024;184(2):144-152. [PubMed 38079178](https://pubmed.ncbi.nlm.nih.gov/38079178/)
6. Dao K, Shechtman S, Weber-Schoendorfer C, et al. Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. BMJ Open. 2024;14(4):e083550. [PubMed 38663923](https://pubmed.ncbi.nlm.nih.gov/38663923/)
7. Brown JP, Huybrechts KF, Straub L, et al. Continuing glucagon-like peptide-1 receptor agonists into the first trimester of pregnancy and pregnancy outcomes: a target trial emulation study using claims information. Ann Intern Med. 2026;179(7):929-937. [PubMed 42258827](https://pubmed.ncbi.nlm.nih.gov/42258827/)
8. Uysal N, Horoz E, Gungor M, et al. Pregnancy outcomes following maternal GLP-1 receptor agonist exposure: a systematic review and meta-analysis. Sci Rep. 2026 (online ahead of print). [PubMed 42420519](https://pubmed.ncbi.nlm.nih.gov/42420519/)
9. Maya J, Pant D, Fu Y, et al. Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation. JAMA. 2025;334(24):2186-2196. [PubMed 41284263](https://pubmed.ncbi.nlm.nih.gov/41284263/)
10. Yu Y, Li X, Groth SW, et al. Gestational weight gain and pregnancy outcomes after semaglutide exposure. Obstet Gynecol. 2026;148(2):229-237. [PubMed 42208070](https://pubmed.ncbi.nlm.nih.gov/42208070/)
11. Hviid KVR, Banasik K, Mortensen LH, et al. Periconceptional GLP-1 receptor agonist exposure and obstetric outcomes: a Danish nationwide cohort study. Hum Reprod Open. 2026;2026(2):hoag015. [PubMed 41852577](https://pubmed.ncbi.nlm.nih.gov/41852577/)
12. Diab H, Fuquay T, Datta P, et al. Subcutaneous semaglutide during breastfeeding: infant safety regarding drug transfer into human milk. Nutrients. 2024;16(17):2886. [PubMed 39275201](https://pubmed.ncbi.nlm.nih.gov/39275201/)
13. Duah J, Seifer DB. Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review. Reprod Biol Endocrinol. 2025;23(1):2. [PubMed 39762910](https://pubmed.ncbi.nlm.nih.gov/39762910/)
14. American College of Obstetricians and Gynecologists. Use of glucagon-like peptide-1 receptor agonists in pregnancy and lactation. Practice Advisory, October 2026. [acog.org](https://www.acog.org/clinical/guidance/practice-advisory/2026/10/use-of-glucagon-like-peptide-1-receptor-agonists-in-pregnancy-and-lactation)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)

Every GLP-1 label's breastfeeding line side by side, what milk studies measured for semaglutide and tirzepatide, why the pills differ, and ACOG's 2026 advice.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)

## Related guides

- Guide · GLP-1s

  ### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

  What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

  Read the guide
- Guide · GLP-1s

  ### [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)

  GLP-1s in menopause: tirzepatide weight loss by menopause stage, semaglutide with hormone therapy, the pill, bone and fractures, and the hot-flash trials.

  Read the guide
- Guide · GLP-1s

  ### [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)

  GLP-1s for PCOS: weight, periods, testosterone and pregnancy rates in the randomized trials, against metformin, plus what the labels say about pregnancy.

  Read the guide
- Guide · GLP-1s

  ### [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)

  The Wegovy pill is daily semaglutide, FDA approved in December 2025. How to take it, its doses beside the weekly shot's, and OASIS 4 next to STEP 1.

  Read the guide
- Guide · GLP-1s

  ### [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)

  Ozempic, Wegovy, Mounjaro and Zepbound side by side: ingredient, approved use, dose steps, top dose, missed-dose rule and trial weight loss, from each FDA label

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [IU (international unit)](https://pepvault.app/glossary/iu)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [MASH](https://pepvault.app/glossary/mash)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
